Evidence map›Paper›PMID 36408828›Full record

ArticleThe EMBO journal2022

Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repair.

Maja Radulovic, Eva Maria Wenzel, Sania Gilani, Lya Kk Holland, Alf Håkon Lystad, Santosh Phuyal, Vesa M Olkkonen, Andreas Brech, Marja Jäättelä, Kenji Maeda and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed
21.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 154 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Lysosomal homeostasis at the crossroads of neurodegeneration.The Journal of clinical investigation · 2026
    Review
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Maja RadulovicCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.ORCID 0000-0002-1322-3647
Eva Maria WenzelCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.
Sania GilaniCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.
Lya Kk HollandCell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Copenhagen, Denmark.ORCID 0000-0001-5386-5022
Alf Håkon LystadCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.
Santosh PhuyalCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.ORCID 0000-0002-1922-2098
Vesa M OlkkonenMinerva Foundation Institute for Medical Research, Biomedicum 2U, Helsinki, Finland.ORCID 0000-0001-5553-7997
Andreas BrechCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.ORCID 0000-0002-9803-1774
Marja JäätteläCell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Copenhagen, Denmark.ORCID 0000-0001-5950-7111
Kenji MaedaCell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Copenhagen, Denmark.
Camilla RaiborgCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.ORCID 0000-0002-5406-5403
Harald StenmarkCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.ORCID 0000-0002-1971-4252
Oslo University Hospital · NODanish Cancer Society · DKUniversity of Copenhagen · DKUniversity of Helsinki · FIUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lysosome integrity is essential for cell viability, and lesions in lysosome membranes are repaired by the ESCRT machinery. Here, we describe an additional mechanism for lysosome repair that is activated independently of ESCRT recruitment. Lipidomic analyses showed increases in lysosomal phosphatidylserine and cholesterol after damage. Electron microscopy demonstrated that lysosomal membrane damage is rapidly followed by the formation of contacts with the endoplasmic reticulum (ER), which depends on the ER proteins VAPA/B. The cholesterol-binding protein ORP1L was recruited to damaged lysosomes, accompanied by cholesterol accumulation by a mechanism that required VAP-ORP1L interactions. The PtdIns 4-kinase PI4K2A rapidly produced PtdIns4P on lysosomes upon damage, and knockout of PI4K2A inhibited damage-induced accumulation of ORP1L and cholesterol and led to the failure of lysosomal membrane repair. The cholesterol-PtdIns4P transporter OSBP was also recruited upon damage, and its depletion caused lysosomal accumulation of PtdIns4P and resulted in cell death. We conclude that ER contacts are activated on damaged lysosomes in parallel to ESCRTs to provide lipids for membrane repair, and that PtdIns4P generation and removal are central in this response.

Indexed as

Receptors, SteroidCholesterolEndoplasmic ReticulumEndosomal Sorting Complexes Required for TransportLysosomesCholesterolEndosomal Sorting Complexes Required for TransportReceptors, Steroidcholesterollysosomemembrane contact sitemembrane repairphosphoinositide

Identifiers

PMID36408828
PMCPMC9753466
OpenAlexW4309511756

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.